Latest Conference Articles

Study Confirms Extending Testing to Every 3 Years in Women Who Test Negative for the HPV Virus

A large-scale study of HPV testing and Pap smear for cervical cancer screening confirms that women can safely extend screening intervals from 1 to 3 years.

PSA Found to Be Highly Predictive of Long-Term Risk of Death From Prostate Cancer

Prostate-specific antigen (PSA) levels can accurately predict the risk of developing metastasis or death from prostate cancer up to 30 years later

Among Women at High Risk for Breast Cancer, Study Finds Smoking, Not Moderate Alcohol Use, Increases Risk of Common Cancers

A prospective study analyzed the risk of contracting common cancers based on baseline self-reporting data on smoking, alcohol use, and physical activity

Stay tuned for Live Conference Coverage from ASCO 2011

ASCO 2011, June 3-7, 2011 McCormick Place, Chicago, IL

Donna Berry on Winning Researcher Award

Donna Berry on the Distinguished Researcher Award and Her Advice to Researchers

ONS President Carl Brown on Key Messages of the Congress

Carlton Brown Describes Key Messages of the ONS Congress

Cancer Survivor Charlie Lustman Lives to Tell His Story

Keynote Presenter Cancer Survivor Charlie Lustman Lives to Tell His Story

Susan Moore on Adapting a Practice for Oral Oncolytics

Susan Moore Oncology Nurse Practitioner/Consultant, MCG Oncology on Adapting a Practice for Use of Oral Oncolytics

Addressing the Challenges of Oral Oncolytic Therapy

Oral oncolytics are frequently used in cancer treatment and they make up approximately 25% of the medications in the oncology pipeline

Cure Magazine Presents Extraordinary Healer Award

Honorary Mistress of Ceremonies Cynthia Nixon kicked off the ONS 36th Annual Congress Cure magazine Extraordinary Healer Award with a rousing tribute

What Nurses May Not Know About Lymphedema

Lymphedema is the treatment-induced buildup of extra lymph fluid in tissues that causes discomforting and potentially debilitating swelling of the limbs

Provenge Treatment Requires Multidisciplinary Care Coordination

At ONS researchers from the Seattle Cancer Care Alliance (SCCA) discussed their multidisciplinary care coordination approach for treating patients with Provenge

Oncology Nurses Explore the Social Media Scene

Social media programs allow oncology nurses to network, share information, and learn evidence-based practices

Ipilimumab's Unique Side Effects Require Unique Management

The FDA recently approved the immunotherapy ipilimumab (Yervoy) as a second-line treatment for patients with metastatic melanoma

Elizabeth Blasiak Discusses the ONS Congress

Elizabeth Blasiak on the Significance of the ONS Congress

Changing Paradigms-Integrating Novel Therapeutics Into the Standard of Care

Prostate cancer affects 1 of every 6 men in the United States

Considerations for Integrating Chemotherapy

Traditional, linear regimen of prostate cancer treatment may need to be reexamined as oncologists learn new ways to incorporate new therapies

Bone-Targeted Therapeutics

Initial clinical findings indicate that results with radiotherapies sometime improve when combined with immunotherapy

Immunotherapies: Avoiding collisions once the brake is released

Immunotherapies again made headlines in oncology last month

Novel Hormone-Radiation Therapy Approaches

Radiation therapy (RT) used in combination with hormonal approaches continues to be a viable strategy for treating localized high-risk prostate cancer patients

PSA: To Screen or Not to Screen

Screening for prostate cancer does work, despite controversy about its efficacy, according to IPCC Co-chair Leonard G. Gomella

Integrating New Hormonal Therapies in Advanced Disease

Hormonal therapies have long been the standard of care for metastatic advanced prostate cancer

Novel vaccine approaches: Prospects for PROSTVAC®-VF are bright

As research into novel vaccine approaches for treating advanced prostate cancer continues...

The Overtreatment of Prostate Cancer

Increased prostate cancer screening has led to overtreatment and has not significantly reduced mortality rates in prostate cancer

Dr. Crawford on Moving Prostate Cancer Field Forward

Dr. Gomella Discusses Interdisiplinary Treatment

Breast Reconstruction Trainee Assessment

In this podcast, Maisam Fazel, FRCS, MS, MB BChir, discusses his research into a checklist for breast cancer surgeons.

Dr. Osman on Designing the Program for the MBCC

Dr. Daniel Osman, director of the Miami Breast Cancer Conference, on Designing the Program for the MBCC

Dr. Fazel on Trends in Surgical Training

Maisam Fazel, FRCS, MS, MB BChir, of Imperial College Healthcare NHS Trust in the United Kingdom on Trends in Surgical Training

Need for Survivorship Plans Emphasized

As the number of breast cancer survivors grows, so does the emphasis on establishing individualized survivorship plans